These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


113 related items for PubMed ID: 973950

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Drugs for dementia.
    Drug Ther Bull; 1975 Oct 24; 13(22):85-7. PubMed ID: 1102280
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Therapeutic possibilities in patients with senile dementia.
    Castleden CM.
    J R Coll Physicians Lond; 1984 Jan 24; 18(1):28-31. PubMed ID: 6323706
    [No Abstract] [Full Text] [Related]

  • 6. Vasodilators in senile dementia.
    Yesavage J.
    Br Med J; 1979 Nov 10; 2(6199):1223-4. PubMed ID: 519381
    [No Abstract] [Full Text] [Related]

  • 7. The efficacy of the cerebral metabolic enhancers in the treatment of senile dementia.
    Branconnier RJ.
    Psychopharmacol Bull; 1983 Nov 10; 19(2):212-9. PubMed ID: 6408682
    [No Abstract] [Full Text] [Related]

  • 8. Drug therapy: cerebral vasodilators (first of two parts).
    Cook P, James I.
    N Engl J Med; 1981 Dec 17; 305(25):1508-13. PubMed ID: 7029283
    [No Abstract] [Full Text] [Related]

  • 9. Effect of cyclandelate on dementia.
    Westreich G, Alter M, Lundgren S.
    Stroke; 1975 Dec 17; 6(5):535-8. PubMed ID: 1101457
    [Abstract] [Full Text] [Related]

  • 10. Cyclandelate in the treatment of multi-infarct dementia. Interim findings from a multicentre study in general practice.
    Blakemore CB.
    Drugs; 1987 Dec 17; 33 Suppl 2():110-3. PubMed ID: 3622304
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Cyclandelate versus flunarizine. A double-blind study in a selected group of patients with dementia.
    Albizzati MG, Bassi S, Calloni E, Sbacchi M, Piolti R, Frattola L.
    Drugs; 1987 Dec 17; 33 Suppl 2():90-6. PubMed ID: 3304956
    [Abstract] [Full Text] [Related]

  • 14. [Methodology of a controlled trial of dihydroergotoxine in acquired intellectual impairment in the adult].
    Dartigues JF, Père JJ.
    Presse Med; 1983 Dec 29; 12(48):3173-5. PubMed ID: 6228936
    [Abstract] [Full Text] [Related]

  • 15. Pathophysiology and psychopharmacology of dementia--a new study design. 2. Cyclandelate treatment--a placebo-controlled double-blind clinical trial.
    Schellenberg R, Todorova A, Wedekind W, Schober F, Dimpfel W.
    Neuropsychobiology; 1997 Dec 29; 35(3):132-42. PubMed ID: 9170118
    [Abstract] [Full Text] [Related]

  • 16. Controlled study of dihydroergotoxine in gerontopsychiatric patients.
    Slánská J.
    Act Nerv Super (Praha); 1989 Apr 29; 31(1):53-5. PubMed ID: 2782002
    [No Abstract] [Full Text] [Related]

  • 17. [Indications for and effects of vasodilating agents, especially in cerebral and peripheral vascular sclerosis].
    Offerhaus L.
    Ned Tijdschr Geneeskd; 1981 Feb 07; 125(6):228-34. PubMed ID: 7207673
    [No Abstract] [Full Text] [Related]

  • 18. The treatment of senile dementia associated with cerebrovascular insufficiency: a comparative study of buflomedil and dihydrogenated ergot alkaloids.
    Jansen W, Bruckner GW, Jansen P.
    J Int Med Res; 1985 Feb 07; 13(1):48-53. PubMed ID: 3884411
    [Abstract] [Full Text] [Related]

  • 19. [A multicenter trial of treatment with slow-release dihydroergotoxine in chronic senile cerebral insufficiency].
    Franchi F, Di Ruvo R, Guggino G, Mazzanti A, Genga A, Cucinotta D.
    G Clin Med; 1982 Jul 07; 63(7):465-81. PubMed ID: 6757035
    [No Abstract] [Full Text] [Related]

  • 20. Drugs for improvement of cerebral function in the elderly.
    Med Lett Drugs Ther; 1976 Apr 23; 18(9):38-9. PubMed ID: 1264019
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.